BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/12/2015 5:09:00 PM | Browse: 1589 | Download: 2914
Publication Name World Journal of Virology
Manuscript ID 19905
Country Thailand
ISSN 2220-3249 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Virology
Manuscript Type Review
Article Title Hepatitis E virus infection: Epidemiology and treatment implications
Manuscript Source Invited Manuscript
All Author List Ga Young Lee, Kittiyod Poovorawan, Duangnapa Intharasongkroh, Pattaratida Sa-nguanmoo, Sompong Vongpunsawad, Chintana Chirathaworn and Yong Poovorawan
Funding Agency and Grant Number
Funding Agency Grant Number
National Research University Project, Office of Higher Education Commission WCU001-HR-57
National Research University Project, Office of Higher Education Commission WCU007-HR-57
National Research University Project, Office of Higher Education Commission WCU-58-006-HR
National Research Council of Thailand
National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project CU56-HR01
Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University RES560530093
Outstanding Professor of Thailand Research Fund DPG5480002
Rachadapisek Sompote Fund of Chulalongkorn University for Postdoctoral Fellowship to Pattaratida Sa-nguanmoo
Corresponding Author Yong Poovorawan, MD, Professor, Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Rama Ⅳ Rd, Bangkok 10330, Thailand. yong.p@chula.ac.th
Key Words Treatments; Blood donors; Adverse effects; Vaccination; Pegylated-interferon; Ribavirin; Hepatitis E
Core Tip Hepatitis E virus (HEV) infection affects indivi-duals in both industrialized and developing countries and can cause acute and chronic hepatitis E. HEV genotypes 1 and 2 are primarily found in developing countries due to waterborne transmission, while the zoonotic potential of genotypes 3 and 4 affects mostly industrialized countries. An awareness of HEV transmission through blood donation, especially in the immunocompromised and solid organ transplant patients, merits an effective anti-viral therapy. The current treatment for HEV infection involving ribavirin and pegylated interferon-α therapy has shown limited efficacy. Although not widely used, an HEV vaccine is available for immunization in China.
Publish Date 2015-11-12 17:09
Citation Lee GY, Poovorawan K, Intharasongkroh D, Sa-nguanmoo P, Vongpunsawad S, Chirathaworn C, Poovorawan Y. Hepatitis E virus infection: Epidemiology and treatment implications. World J Virol 2015; 4(4): 343-355
URL http://www.wjgnet.com/2220-3249/full/v4/i4/343.htm
DOI http://dx.doi.org/10.5501/wjv.v4.i4.343
Full Article (PDF) WJV-4-343.pdf
Full Article (Word) WJV-4-343.doc